Following a successful trial at the National Centre for Infectious Diseases (NCID), the company said on Thursday (Oct 29) that it is currently in discussions with the Health Ministry (MOH) to deploy its breathalyser tests in trials at public locations in the coming months.
In particular, instead of swab tests, new breath analyser devices developed by the National University of Singapore’s Nanoscience and Nanotechnology Institute that can detect lung cancer and tuberculosis can be re-purposed for the mass screening of COVID-19 for real-time and on-site analysis.
Commentary: The systematic testing Singapore needs to ditch circuit breakers for good Read More »
Dr Jia said: “I thought I was going to end up as a research scientist, but NUS made me see the potential of converting my idea into an actual invention that can help save lives.”
The Straits Times: NUS helps PhD students get a Grip on enterprise Read More »
Last Tuesday, the National University of Singapore (NUS
The Straits Times: NUS to help launch tech-based start-ups Read More »
